KFDA likely to assess clinical effectiveness of new chemically modified medicines

The Korea Food and Drug Administration is expected to evaluate the clinical effectiveness of new chemically modified medicines with an improved dosage and administration in the process of granting its market authorization, according to the Ministry of Health, Welfare and Family Affairs.

If this is the case, the nation’s health watchdog will play a primary role in assessing the economic effe...